Jun 122007
A class action lawsuit has been filed in New York against pharmaceutical giant GlaxoSmithKline regarding their diabetes drug, Avandia. According to the lawsuit, GlaxoSmithKline failed to disclose that Avandia increased the risk for heart attack in patients taking the drug.
After recent congressional hearings, the U. S. Food and Drug Administration has asked the pharmaceutical company to place a “black box” warning on the diabetes drug, which indicates the most serious of warnings jus short of pulling a drug from the market. The study citing the increased risk of heart attack was published in the New England Journal of Medicine.
Sorry, the comment form is closed at this time.